TABLE 2.
Liver Biochemistries of Patients
Patient No. | Disease Control Diagnosis | Age (years) | Sex | Total Bilirubin (mg/dL) | ALT (IU/L) | AST (IU/L) |
---|---|---|---|---|---|---|
1 | Hepatoblastoma | 3.32 | Female | 0.40 | 29 | 27 |
2 | Hepatoblastoma | 3.39 | Male | 0.20 | 46 | 63 |
3 | Methylmalonic acidemia | 1.65 | Female | 0.60 | 22 | 61 |
4 | Ornithine transcarbamylase deficiency | 2.56 | Female | 0.30 | 312 | 331 |
PNAC Group Diagnosis | Age (years) | Sex | Total Bilirubin (mg/dL) | ALT (IU/L) | AST (IU/L) | |
5 | PNAC | 0.10 | Female | 12.10 | 101.00 | 118.00 |
6 | PNAC | 0.25 | Female | 8.30 | 226.00 | 213.00 |
7 | PNAC | 0.08 | Male | 4.00 | 48.00 | 82.00 |
8 | PNAC | 1.02 | Male | 63.2 | 172 | 430.00 |
9 | PNAC | 0.18 | Female | 4.80 | 182.00 | 230.00 |
10 | PNAC | 0.30 | Female | 5.70 | 36.00 | 70.00 |
11 | PNAC | 0.50 | Male | 2.90 | 485.00 | 396.00 |
Group | Total Bilirubin (mg/dL) (mean ± SEM) | ALT (IU/L) (mean ± SEM) | AST (IU/L) (mean ± SEM) | |||
| ||||||
Disease controls | 0.38 ±0.09 | 102.25 ± 70.10 | 120.50 ± 70.65 | |||
PNAC | 14.43 ± 8.21 | 178.57 ± 57.65 | 219.86 ± 55.03 | |||
Liver Biochemistry | Disease Controls vs. PNAC P Value | |||||
| ||||||
Total bilirubin | <0.0001 | |||||
ALT | ns | |||||
AST | ns |
Abbreviation: ns, not significant.